Navigation Links
Peregrine in Medical News

Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections

--PS-Targeting AntibodiesMay Represent a Completely New Class of Drugs with Broad Potential to Treat Life-Threatening Viral Infections-- --Peregrine's Clinical-Stage Anti-PS Agent Bavituximab and Equivalent Antibodies Cured Lethal Viral Infections in Preclinical Models-- --Data C...

Positive Results From Peregrine Pharmaceuticals' Bavituximab Phase l HCV Trial Presented at AASLD Meeting

- Bavituximab Appeared Generally Safe and Well Tolerated at All Doses Tested - - Signs of Anti-viral Activity Seen at All Dose Levels - - Exploratory Analysis of Cytokine Profile Following Treatment Supports Proposed Immunomodulatory Mechanism ...

Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009

...USTIN, Calif. , July 14 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ), today ann...addition to manufacturing revenues, during FY 2009 peregrine generated revenues from services provided under it...percent in FY 2009 compared to FY 2008. peregrine reported a consolidated net loss of $3,609,000, or...

New Report Just Published: World Hepatitis C Virus And Therapeutics Market Report

...Nabi Biopharmaceuticals Starts Proof-Of-Concept Trial for Civacir II-60 peregrine Announces Positive Results for Bavituximab II-60 Jenken to Commence Pha...66 Roche Inks Licensing Deal with Novartis and Ortho-Clinical II-66 peregrine Opens Subsidiary in China II-66 InterMune Completes Production Mileston...

Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial

... TUSTIN, Calif., June 30 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today anno...n reached even at the highest planned dose level. peregrine has now begun designing additional bavituximab can... posted at www.peregrineinc.com . About peregrine Pharmaceuticals ...

Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Vascular Imaging Applications of Its PS-Targeting Platform

... TUSTIN, Calif., June 24 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today repo...ty of Texas System and is exclusively licensed to peregrine Pharmaceuticals. 1. M Jennewein, M Lewis, D Z... posted at www.peregrineinc.com . About peregrine Pharmaceuticals ...

ASCO Research Foundation Grant Will Support Study of Peregrine's Bavituximab in Lung Cancer

... TUSTIN, Calif., June 10 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today anno... posted at www.peregrineinc.com . About peregrine Pharmaceuticals peregrine Pharmaceuticals, Inc. is a biopharmaceutical compa...

Beacon Equity Issues Stock Alerts on Leading Pharmaceutical Giants

... stock alerts for free by visiting BeaconEquity.com/m . Today's Stock Alerts include: Angiotech Pharmaceuticals Inc. (Nasdaq: ANPI ), peregrine Pharmaceuticals Inc. (Nasdaq: PPHM ), Biogen Idec Inc. (Nasdaq: BIIB ), Genzyme Corp. (Nasdaq: GENZ ), Celgene Corp. (Nasdaq: CELG ) and Gilea...

Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program

... TUSTIN, Calif., May 28 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical...ls, visit www.clinicaltrials.gov . About peregrine Pharmaceuticals peregrine Pharmaceuticals, Inc. is a biopharmaceutical compa...

Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQ's Minimum Bid Price Rule

...TUSTIN, Calif., March 25 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today annou...it has received a letter from NASDAQ that provides peregrine with an additional three months to regain compliance with the minimum bid price rule. peregrine now has until October 26, 2009 to regain complianc...
Peregrine in Medical Technology

Affitech-Discovered Anti-PS Antibodies in Development by Peregrine Pharmaceuticals Show Excellent Functionality in Preclinical Studies

OSLO, Norway, April 28 /PRNewswire/ -- Affitech AS, the human antibody therapeutics company, announced today that preclinical data on two fully human anti-PS (phosphatidylserine) antibodies were presented by its collaboration partner Peregrine Pharmaceuticals at the 100th Annual Meeting of the...

New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models

-- Data Presented at Anti-Angiogenesis Conference Shows R84, the Selective Human Anti-VEGF Antibody Developed by Peregrine in Association with Affitech, Is Equivalent to Avastin in Inhibiting Growth of Established Tumors in a Preclinical Breast Cancer Model -- -- R84 Is Being ...

Positive Results Using Affitech-Identified Human Antibody That Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model Reported by Peregrine

OSLO, Norway--(BUSINESS WIRE)--Apr 23, 2007 - Affitech AS, the human antibody therapeutics company announced today that Peregrine Pharmaceuticals, Inc. reported positive in vivo test results of R3, a fully human monoclonal antibody developed by Affitech, in a pancreatic cancer model at the recently...

Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials

... TUSTIN, Calif., June 3 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today high... posted at www.peregrineinc.com . About peregrine Pharmaceuticals peregrine Pharmaceuticals, Inc. is a biopharmaceutical compa...

Peregrine Pharmaceuticals Completes Patient Enrollment in its Phase II Trial of Bavituximab Plus Docetaxel in Breast Cancer Patients

... TUSTIN, Calif., May 4 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today annou...nced solid cancers is also continuing. About peregrine Pharmaceuticals peregrine Pharmaceuticals, Inc. is a biopharmaceutical compa...

Data Presented at AACR Annual Meeting Show Anti-Tumor Activity of Peregrine's Fully Human Anti-PS Antibody in Prostate Cancer Model

...TUSTIN, Calif., April 22 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical...hia (PA): AACR; 2009. Abstract nr 5463 About peregrine Pharmaceuticals peregrine Pharmaceuticals, Inc. is a biopharmaceutical compa...

Studies Presented at AACR Annual Meeting Highlight Multiple Immunomodulatory Mechanisms of Peregrine's PS-Targeting Antibodies

...TUSTIN, Calif., April 21 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ), a clinica... Medical Center in Dallas, a scientific advisor to peregrine and co-author of one of the AACR presentations. "...f preclinical studies by a team of scientists from peregrine Pharmaceuticals and Affitech A/S used a fully huma...

Peregrine Pharmaceuticals Reports Positive Preliminary Data From Phase II Bavituximab Lung Cancer Trial

...TUSTIN, Calif., April 20 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ), today ann...d solid cancers is also continuing. About peregrine Pharmaceuticals peregrine Pharmaceuticals, Inc. is a biopharmaceutical compa...

Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial

...tion Criteria in Solid Tumors (RECIST) criteria. peregrine president and CEO, Steven W. King noted, "We are v...advanced solid cancers is also continuing. About peregrine Pharmaceuticals peregrine Pharmaceuticals, Inc. is a biopharmaceutical compa...

Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer

... - peregrine Achieves Milestone as Third Phase II Trial in Its ...CH) and Good Clinical Practices (GCP) standards. peregrine recently reported that a Phase II trial assessing ...advanced solid cancers is also continuing. About peregrine Pharmaceuticals ...

More>>

Peregrine in Biological News

Peregrine's PS-targeting antibodies highlighted in AACR Annual Meeting studies

... Medical Center in Dallas, a scientific advisor to peregrine and co-author of one of the AACR presentations. "...f preclinical studies by a team of scientists from peregrine Pharmaceuticals and Affitech A/S used a fully huma...argeting antibodies," said Dr. Monica Friedrich, a peregrine research scientist and lead author of the study. ...

Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections

... TUSTIN, Calif., November 23, 2008 -- peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) today reported publication of data in Nature Medicine that supports the broad anti-viral potential of the compa...

KAUST and IBM to build 1 of the fastest and most powerful supercomputers

... computational sciences, and contribute to the further development of a knowledge-based society in Saudi Arabia. Shaheen is the Arabic word for the peregrine falcon, a bird which can reach dive speeds of up to 213 miles (or 342 kilometers) per hour. Similarly, the 16-rack Blue Gene/P System , capable of 2...

Recovery efforts not enough for critically endangered Asian vulture

...ersity of North Texas in Denton. "We just need to get diclofenac out of the environment and more birds into protection before it is too late." The peregrine Fund, a organization that works to conserve birds of prey in nature, is trying to prevent the birds' extinction, but it's an effort that requires mone...

Endangered shortnose sturgeon saved in Hudson River

...cetera," said Bain. Since 1966 when the federal government started identifying threatened species, only 16, including the American alligator, American peregrine falcon and brown pelican, have recovered. "Recovery is very rare," said Bain, who has been monitoring the shortnose sturgeon's population since the mi...
Peregrine in Biological Technology

Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program

- Agency Confirms Its Continuing Interest in Peregrine's Anti-PS Technology for Biodefense Applications - TUSTIN, Calif., Dec. 14 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ), a clinical stage biopharmaceutical company developing monoclonal antib...

Peregrine Pharmaceuticals to Present at the Jesup & Lamont 2009 Growth Stock & National Sales Conference

... TUSTIN, Calif., July 23 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today anno...www.jesuplamontconferences.com . About peregrine Pharmaceuticals peregrine Pharmaceuticals, Inc. is a biopharmaceutical compa...

Peregrine Pharmaceuticals Licenses Anti-VEGF Antibodies to Affitech

...RSHOLM, Denmark, July 22 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) and Affite...elopment and potential product commercialization. peregrine will receive an upfront payment, research fees and...ally totaling in the double-digit millions (US$). peregrine will also receive royalties on any future sales an...

Jesup & Lamont Announces Presenting LifeTech Companies and Former FDA Commissioner at Annual Growth Stock & National Sales Conference

...ave such a diversified group of innovative biotech companies presenting at our conference." Some of the companies presenting on July 30th include peregrine Pharmaceuticals (Nasdaq: PPHM ), Cytori Therapeutics (Nasdaq: CYTX ), NovaBay Pharmaceuticals (Amex: NBY ), Nabi Biopharmaceuticals (Nasdaq: N...

New Report Just Published: World Prostate Cancer Therapeutics Market Report

...on CB7630 in Patients with Prostate Cancer II-54 Ambrilia Unveils Results of PCK3145 in Patients with Metastatic Prostate Cancer II-54 peregrine Pharmaceuticals Reveals Pre-Clinical Data on Bavituximab in Prostate Cancer II-54 Cell Genesys Reveals Data of GVAX Immunotherapy for Treatmen...

Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine

... TUSTIN, Calif., July 1 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today anno.... Parseghian, Ph.D., senior director of R&D at peregrine and senior author of the new publication, commente...umber 1 638 989. It was developed by inventors at peregrine and the Paul Scherrer Institute in Switzerland, wh...

Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrine's Cotara(R) for the Treatment of Brain Cancer

... TUSTIN, Calif., June 16 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today repo...als, visit www.clinicaltrials.gov . About peregrine Pharmaceuticals peregrine Pharmaceuticals, Inc. is a biopharmaceutical compa...

Peregrine Pharmaceuticals Presents Promising Data From Its Phase II Bavituximab Breast Cancer Trial at 2009 ASCO Annual Meeting

...d TUSTIN, Calif., June 1 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today anno...n or treatment discontinuation. Separately, peregrine reported that researchers will present data at ASC...vel 2, West Hall C Abstract No: 1080 About peregrine Pharmaceuticals ...

Clinical Data on Peregrine's Bavituximab Cancer Program to Be Discussed in Two Presentations at 2009 ASCO Annual Meeting

... TUSTIN, Calif., May 27 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical...omepage at www.peregrineinc.com . About peregrine Pharmaceuticals peregrine Pharmaceuticals, Inc. is a biopharmaceutical compa...

Peregrine Pharmaceuticals Reports Positive Data in Second Phase II Bavituximab Breast Cancer Trial

...TUSTIN, Calif., April 27 /PRNewswire-FirstCall/ -- peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ), today ann...d solid cancers is also continuing. About peregrine Pharmaceuticals peregrine Pharmaceuticals, Inc. is a biopharmaceutical compa...
Peregrine in Biological Dictionary

Genetic diversity

...ans a greater ability for ... World Resources Institute: Genetic Diversity ... Statement on Genetic Diversity . This is a statement from the peregrine Fund on genetic diversity . Shattering ... Genetic Diversity - Research - Harvard Malaria Initiative - Harvard School of Public Health ... U...
Other Tags
(Date:12/22/2014)... Petersburg, FL (PRWEB) December 22, 2014 Christmas ... Sublime Beauty® has a fast and easy solution that will ... gift cards can be purchased from from $25 up to ... "We offer 100% customer satisfaction and a wide array of ... have no fees and no expiration dates. , Gift ...
(Date:12/22/2014)... The NLN’s 2015 Leadership ... this month. Faculty have been selected through competitive ... fast-tracked for administrative leadership roles within their academic ... Simulation Educators, featuring a curriculum uniquely devised for ... , Twenty nurse educators were chosen for ...
(Date:12/21/2014)... 22, 2014 Recently, BambooFlooringChina.com, a famous ... woven bamboo flooring collection , and launched a bamboo ... promotion is valid until Jan. 30, 2015. , According ... is the hardest bamboo flooring available today; it has ... of traditional teak hardwoods. Strand woven bamboo is made ...
(Date:12/21/2014)... Gables, FL (PRWEB) December 21, 2014 When ... head lice, who do they call? The new answer is ... Blvd, Coral Gables FL 33134, their newest treatment center will ... this pest quickly, conveniently and without the use of harmful ... Opening is scheduled for January 1, 2015. Like the company’s ...
(Date:12/21/2014)... 2014 Recently, one of the best ... Prom Shop has introduced its new collection of ... big discounts on all its prom dresses & other ... insists on providing top quality dress products and great ... considered as one of the best prom dresses online ...
Breaking Medicine News(10 mins):Health News:NLN Leadership Institute Announces 2015 Cohorts 2Health News:NLN Leadership Institute Announces 2015 Cohorts 3Health News:BambooFlooringChina.com Announced Its Durable Strand Woven Bamboo Flooring Collection 2Health News:All-Natural Florida Lice Removal Company Opens New Lice Treatment Salon In South Florida 2Health News:New Prom Dresses From One Of The Best Prom Dresses Online Shops, LunaDress Prom Shop 2
(Date:11/21/2014)... , November 18, 2014 According ... Market by Systems (Video, RFID, Access Control, Intrusion Detection, ... Hotels, Banks, Government), Component Service Geography - Global Forecasts ... Market is projected to be around $25 Billion in ... 2020, growing at a CAGR of 8.69%. ...
(Date:11/21/2014)... Nov. 20, 2014   Atmel® Corporation (NASDAQ: ... (MCU) and touch technology solutions, today launched the industry,s ... with the widest V cc range from 1.7V ... and faster I 2 C bus communication speeds, and ... memory making them ideal for consumer, industrial, computer, and ...
(Date:11/18/2014)... 18, 2014   EyeLock Inc. , a ... MorphoTrust USA (Safran), a leading U.S. ... a strategic partnership to offer comprehensive biometric identity ... (MVA), airport screening and financial services markets. ... serves consumers through a nationwide network of 1,100 ...
Breaking Biology News(10 mins):Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
Other Contents